Unsustained complete response of less than 24 months after autologous stem cell transplantation predicts aggressive myeloma with short survival-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Unsustained complete response of less than 24 months after autologous stem cell transplantation predicts aggressive myeloma with short survival

Published:2014-01-29 Issue:4 Volume:32 Page:205-211
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol Oncol

Author:

Chim Chor Sang¹,Liu Herman²,Lie Albert Kwok Wai¹,Chan Eric Yuk Tat³,Ho Sandy⁴,Wong Michael⁵,Kwong Yok Lam¹

Affiliation:

1. Department of Medicine, Queen Mary Hospital; University of Hong Kong; Hong Kong

2. Department of Medicine; Pamela Youde Nethersole Eastern Hospital; Hong Kong

3. Department of Pathology, Queen Mary Hospital; University of Hong Kong; Hong Kong

4. Department of Medicine; Princess Margaret Hospital; Hong Kong

5. Department of Pathology; Princess Margaret Hospital; Hong Kong

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference19 articles.

1. The role of complete response in multiple myeloma;Harousseau;Blood,2009

2. Importance of achieving a complete response in multiple myeloma, and the impact of novel agents;Chanan-Khan;J Clin Oncol,2010

3. Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study;Cavo;The Lancet,2010

4. Lenalidomide maintenance after stem-cell transplantation for multiple myeloma;Attal;N Engl J Med,2012

5. Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma;Ladetto;J Clin Oncol,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approaching the first relapse after autologous transplant in multiple myeloma;ADVANCES IN CELL AND GENE THERAPY;2020-07-20

2. Obtaining a complete response correlated with survival in multiple myeloma;HEMATOLOGIE;2019

3. Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapse;Leukemia;2018-10-15

4. Analysis of long-term survival in multiple myeloma after first-line autologous stem cell transplantation: impact of clinical risk factors and sustained response;Cancer Medicine;2017-12-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3